Anesthesia Monitoring Devices Market To Gain From Rising Safety Awareness Amongst The Physicians And The Soaring Volume Of Surgeries Till 2024: Grand View Research, Inc.

The anesthesia monitoring devices market is expected to reach USD 1.9 billion by 2024, according to a new report by Grand View Research, Inc. The growing geriatric population base and the spiraling number of surgeries are anticipated to boost the market growth. Geriatric patients are the target population for this industry as they are highly prone to various chronic disorders and are at a higher risk of developing complications.

The rising awareness amongst the physicians about the various factors that affect patient outcomes, such as the choice of anesthetic drug, the appropriate route of administration, and the right dose of the anesthetic agent, as well as the monitoring of the depth of anesthesia is likely to accelerate the growth of the market during the forecast period.

Technological advancements in terms of accuracy, portability, and affordability have resulted in the increased usage of these monitoring devices. For instance, the introduction of the new generation, microprocessor-based intelligent anesthesia systems with integrated monitors enables monitoring of various parameters along with the precisely-controlled administration of the anesthetic agent.

View summary of this report @ http://www.grandviewresearch.com/industry-analysis/anesthesia-monitoring-devices-market

Further key findings from the study suggest:

  • Amongst the product type segments, the advanced anesthesia monitors segment held a lucrative share of over 60.0% in 2015 owing to its durability, reliability, and accuracy. Moreover, these devices monitor various significant parameters such as oxygen saturation level, carbon dioxide level, heart rate, and blood pressure.
  • The hospitals in the end-use segment exhibited remunerative growth in 2015; this can be attributed to the presence of advanced diagnostic and therapeutic medical technologies that enables both, faster and accurate diagnosis. Moreover, the availability of these advanced systems coupled with the presence of skilled personnel contributes towards profitable growth of this segment.
  • North America dominated the overall market with a revenue share of over 35.0% in 2015 owing to the presence of well-developed health care settings and the presence of a favorable reimbursement network, government funding, and increasing health awareness levels amongst the people.
  • However, Asia Pacific is anticipated to be the fastest growing region with a CAGR of about 11.0% over the forecast period. The economic developments and the advancing healthcare system with the aid of supportive government initiatives are collectively anticipated to further assist the growth in this region.
  • Some key players operating in the anesthesia monitoring devices market include Masimo Corporation, Infinium Medical, Inc., Medtronic plc, GE Healthcare, Nihon Kohden Corporation, Philips Healthcare, Mindray Medical International Ltd., Drägerwerk AG & Co. KGaA, and Schiller AG. New product development, mergers, and collaborations are some key initiatives taken to sustain themselves in the competition.
  • For instance, Masimo Corporation incorporated Oxygen Reverse Index (ORI) which measures the oxygen levels and provides real-time information with regard to the patient’s oxygen reserve in synchronization with the partial pressure of oxygen to prevent hyperoxia conditions (oxygen levels above normal) in patients that are receiving auxiliary oxygen supply whilst undergoing surgery.

Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented anesthesia monitoring devices market on the basis of product type, end-use, and region.

Global Anesthesia Monitoring Devices Market By Product Revenue, (USD Million) 2013 – 2024

  • Advanced Anesthesia Monitors
    • Anesthesia Gas Monitors
    • Monitors Measuring Depth of Anesthesia
    • Standalone Capnography Monitors
    • Others
  • Basic Anesthesia Monitors
  • Integrated Anesthesia Monitors

Global Anesthesia Monitoring Devices Market By End-Use Revenue, (USD Million) 2013 – 2024

  • Hospitals
  • Ambulatory Settings
  • Others

Anesthesia Monitoring Devices Market By Region Revenue, (USD Million) 2013 – 2024

  • North America
    • S.
    • Canada
  • Europe
    • UK
    • Germany
  • Asia Pacific
    • Japan
    • China
  • Latin America
    • Brazil
    • Mexico
  • MEA
    • South Africa
    • Saudi Arabia

Access press release of this report – http://www.grandviewresearch.com/press-release/global-anesthesia-monitoring-devices-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

For more information visit – http://www.grandviewresearch.com/

Advertisements

Anti-Drone Market To Gain From Increased Demand In Military And Defense Sectors Till 2024: Grand View Research, Inc.

The global anti-drone market size is anticipated to reach USD 1.85 billion by 2024, according to a new report by Grand View Research, Inc. The increase in the adoption of UAVs/drones has resulted in the commencement of another market that focuses on a solution for rogue drones, complete with net-firing bazookas, electromagnetic shields, and anti-drone death rays.

The steep rise in the adoption of drones for commercial as well as recreational purposes has increased concerns regarding aerials attack and threats. Detection and identification of these unmanned aircraft systems have become a vital factor for the maintenance of the security. Various institutions across the world are increasingly deploying counter drone measures to address the ever-growing need for safety and security.

As UAVs become deadlier, stealthier, faster, agile, smaller, sleeker, and cheaper, the nuisance and threats posed by them are expected to grow at numerous levels, ranging from personal/domestic privacy to national security. With that in mind, there is significant effort both in terms of money and technology being invested in the development of anti-drone technologies.

Various national security agencies across the world have started to precisely understand the potential threats from drones and increasingly considering commercial as well as consumer drones as the new major threat to the world. It is only a matter of time before redundant and reliable methods of countering drones become mainstream and widely available.

Several busy airports and hubs across the world are seeking defense measures and regulations to protect their airliners and harbored aircraft from drones straying into commercial airspace and posing innumerable threats of a collision. The detection of a range of drone types is expected to require multiple modalities, data fusion systems to effectively identify and detect target drones amongst a cluttered background.

View summary of this report @ http://www.grandviewresearch.com/industry-analysis/anti-drone-market

Further key findings from the report suggest:

  • Manufacturers across the world are increasingly developing innovative solutions to detect smaller recreational drones through their acoustic signature and visually
  • Asia Pacific is expected to witness the highest growth over the forecast period owing to increasing government spending in the expansion of aerospace and defense infrastructure across emerging economies
  • Electronic countermeasures are anticipated to emerge as a lucrative segment over the next eight years as these measures involve the use of high power electromagnetic and high power microwave weapons to prevent successful transmission and reception of drone signals
  • Various drone manufacturers, including DJI, have already started integrating “no fly zone” restrictions directly onto the onboard firmware in some of their products
  • Numerous reports of drone sightings have been coming from various members of the airspace system, which in turn is presumed to propel the adoption of counter-UAV systems in commercial venues

Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/emerging-and-next-generation-technologies

Grand View Research has segmented the global anti-drone market on the basis of mitigation type, defense type, end-use, and region.

Anti-Drone Mitigation Type Outlook (Revenue, USD Million; 2014-2024)

  • Destructive
    • Laser System
    • Missile Effector
    • Electronic Countermeasures
  • Non-Destructive

Anti-Drone Defense Type Outlook (Revenue, USD Million; 2014-2024)

  • Detection & Disruption
  • Detection

Anti-Drone End-Use Outlook (Revenue, USD Million; 2014-2024)

  • Military & Defense
  • Commercial
  • Government
  • Others

Anti-Drone Regional Outlook (Revenue, USD Million; 2014-2024)

  • North America
    • S.
    • Canada
  • Europe
    • UK
    • Germany
  • Asia Pacific
    • China
    • Japan
  • Latin America
  • Middle East and Africa (MEA)

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

For more information visit – http://www.grandviewresearch.com/

Amino Acids Market To Gain From Increasing Meat Consumption Coupled With High Livestock Production Such As Swine, Broiler And Cattle Till 2022

The Global Amino Acids Market is expected to reach USD 35.40 billion by 2022, according to a new study by Grand View Research, Inc. Global increase in livestock production on account of increasing meat consumption is expected to remain a key driving factor for amino acids market over the next seven years. Increase in dietary supplements demand owing to growing geriatric population and improved health standards particularly in emerging markets of Asia Pacific and Latin America is also expected to have a positive influence on the market growth. Increase in flavor enhancing products such as aspartame derived from l-aspartic acid and phenylalanine owing to increasing food & beverages consumption is expected to fuel market growth further. Steady supply of key raw material is expected to remain a key challenge for market participants over the forecast period.

L-glutamic acid emerged as the leading amino acid product segment and accounted for over 40% of total market volume in 2014. Lysine, threonine, methionine and tryptophan are majorly consumed feed additives for livestock production. Tryptophan is expected to be the fastest growing amino acid with an estimated CAGR of 18.0% from 2015 to 2022. Ban on bone meal across various regional markets is expected to remain a key driving factor for this segment over the forecast period.

View summary of this report @ http://www.grandviewresearch.com/industry-analysis/amino-acids-market

Further key findings from the study suggest:

  • Global amino acids market demand was 6,582.0 kilo tons in 2014 and is expected to reach 10,117.5 kilo tons by 2022, growing at a CAGR of 5.6% from 2015 to 2022.
  • Plants were the leading source for manufacturing amino acids and accounted for 86.0% of the total market volume in 2014. Animal based amino acids are expected to grow at an estimated CAGR of 4.0% from 2015 to 2022.
  • Animal feed was the leading application segment and accounted for 52.5% of the total market volume in 2014. It is also expected to witness the highest growth of 6.2% from 2015 to 2022. Recent disease outbreak has prompted the demand for amino acids in animal feed, which is expected to drive this segment. Global amino acids demand for pharmaceuticals is expected to register a growth of 5.6% from 2015 to 2022.
  • Asia Pacific dominated the global amino acids market and accounted for 49.4% of total demand in 2014. Increasing livestock production particularly in China, India and South East Asian countries is expected to drive the regional market over the forecast period. Central & South America is expected to witness the highest growth of 6.5% from 2015 to 2022. Increasing meat consumption coupled with growing health awareness particularly in Brazil is expected to drive the regional market.
  • Global amino acids market is highly competitive with presence of large scale and small scale companies. Some major companies operating in the global amino acids market include Ajinomoto Co., Cargill Inc., Evonik Industries AG, ADM, Prinova U.S. LLC, Royal DSM. Other industry participants include Iris Biotech GmbH, Nanjing Liang Chemical, Sunrise Nutrachem Group, Tokyo Chemical Industry, Novus International Inc., Anaspec Inc., CJ Cheil Jedang Corporation and Adisseo France SAS.

Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/animal-feed-and-feed-additives

For the purpose of this study, Grand View Research has segmented the amino acids market on the basis of source, application and region:

Global Amino Acids Product Outlook (Volume, Kilo Tons; Revenue, USD Million, 2012 – 2022)

  • L-Glutamate
  • Lysine
  • Methionine
  • Threonine
  • Tryptophan
  • Leucine
  • Iso-leucine
  • Valine
  • Glutamine
  • Arginine
  • Glycine
  • Phenylalanine
  • Tyrosine
  • Citrulline
  • Creatine
  • Proline
  • Serine
  • Others

Global Amino Acids Source Outlook (Volume, Kilo Tons; Revenue, USD Million, 2012 – 2022)

  • Plant based
  • Animal based

Global Amino Acids Application Outlook (Volume, Kilo Tons; Revenue, USD Million, 2012 – 2022)

  • Animal Feed
    • Animal feed by livestock
      • Swine
      • Poultry
      • Cattle
      • Others
    • Food & dietary supplements
    • Pharmaceuticals

Global Amino Acids Regional Outlook (Volume Kilo Tons; Revenue, USD Million, 2012 – 2022)

  • North America
    • S.
  • Europe
    • Germany
    • France
    • UK
  • Asia Pacific
    • China
    • Japan
    • India
  • Central & South America
  • Middle East & Africa

Access press release of this report – http://www.grandviewresearch.com/press-release/global-amino-acids-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

 

Contact:

Sherry James

Corporate Sales Specialist, U.S.A.

Grand View Research, Inc.

United States

Phone:  1-415-349-0058

Toll Free:  1-888-202-9519

Email:  sales@grandviewresearch.com

For more information visit – http://www.grandviewresearch.com/

Thermoformed Plastics Market Is Expected To Grow At A CAGR Of 4.2% From 2014 To 2025: Grand View Research, Inc.

The global thermoformed plastics market is expected to reach USD 16.28 billion by 2025, according to a new report by Grand View Research, Inc. Globally, increasing demand for medical and pharmaceutical products has been a major factor driving market growth. Also, growing healthcare industry has led to rising demand for thermoformed plastics.

Rising demand in various application sectors including food packaging, automotive, healthcare & medical, electrical & electronics, construction, and consumer goods & appliances owing to cost efficient nature is projected to propel the market over the coming years. Rapid industrialization, infrastructural, and medical activities is anticipated to augment the market growth from 2017 to 2025.

Thermoforming is a process where a sheet of plastic is heated to make it flexible then fabricated and molded in required shape to make it a usable product. Different methods used for processing thermoformed plastics are thin gauge thermoforming, thick gauge thermoforming, plug assist forming, and vacuum snapback.

Thin gauge thermoforming was projected to be the largest segment over the forecast period with a market share of 35% in terms of revenue in 2016. High labor cost and fluctuation raw material prices are major factors which negatively impact the market growth. Asia Pacific is the fastest growing segment with potential growth opportunities. Rising demand from industries such as automotive, medical, food packaging, construction, and pharmaceuticals in this region is expecting to boost the market over the forecast period.

North America is expected to observe the significant regional segment over the next eight years with an estimated CAGR in terms of revenue of around 4.8% from 2017 to 2025. Increasing manufacturers and suppliers of thin gauge thermoforming plastics in this region such as Placon, Vitalo, Peninsula Plastics, among others is anticipated to spur the market growth.

View summary of this report @ http://www.grandviewresearch.com/industry-analysis/thermoformed-plastics-market

Further key findings from the report suggest:

  • The global thermoformed plastics demand exceeded 380 kilo tons in 2016 and is expected to grow at a CAGR of 4.2% from 2017 to 2025
  • Polypropylene emerged as the largest product segment in 2016 and is estimated to generate revenue over USD 3.5 billion by 2025
  • Polymethyl methacrylate (PMMA) is expected to be the fastest growing product segment owing to its high resistance nature towards UV light and extensive flexible properties
  • Thin gauge thermoforming was projected to be the largest process segment and is anticipated to witness moderate growth over the next eight years
  • Automotive sector was 36 kilo tons in 2016 and is expected to grow at a CAGR of 4.8% over the forecast period
  • Food packaging was the significant application segment in 2016 and is projected to grow at a moderate rate owing to increasing consumption of ready to eat food is expected to boost this segment
  • The food and medical packaging industry in Asia Pacific is projected to witness significant growth over the next eight years owing to various developments across major economies and increasing per capita income. The regional market in terms of revenue is expected to grow at a CAGR of 5.2% from 2017 to 2025.
  • Key players including Pactiv LLC, D&W Fine Pack LLC, Genpak LLC, and Sonoco Plastics dominated the global thermoformed plastics market accounting for significant share of the total volume in 2016

Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/plastics-polymers-and-resins

Grand View Research has segmented the global thermoformed plastics market on the basis of product, process, application, and region:

Product Outlook (Volume, Kilo Tons; Revenue, USD Million, 2014 – 2025)

  • Polymethyl Methacrylate (PMMA)
  • Bio-degradable polymers
  • Polyethylene (PE)
  • Acrylonitrile Butadiene Styrene (ABS)
  • Poly Vinyl Chloride (PVC)
  • High Impact Polystyrene (HIPS)
  • Polystyrene (PS)
  • Polypropylene (PP)

Process Outlook (Volume, Kilo Tons; Revenue, USD Million, 2014 – 2025)

  • Plug assist forming
  • Thick gauge thermoforming
  • Thin gauge thermoforming
  • Vacuum snapback

Application Outlook (Volume, Kilo Tons; Revenue, USD Million, 2014 – 2025)

  • Healthcare & medical
  • Food packaging
  • Electrical & electronics
  • Automotive
  • Construction
  • Consumer goods & appliances
  • Others

Regional Outlook (Volume, Kilo Tons; Revenue, USD Million, 2014 – 2025)

  • North America
    • S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
  • Asia Pacific
    • China
    • Japan
    • India
  • Central & South America
  • Middle East & Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

For more information visit – http://www.grandviewresearch.com/

Ammunition Market Size Is Projected To Reach $16.07 Billion By 2024: Grand View Research, Inc.

The global ammunition market is expected to reach USD 16.07 billion by 2024, according to a new report by Grand View Research, Inc. Increasing terrorist activities, coupled with arms race amongst emerging economies in the recent past is projected to fuel industry growth over the next eight years. Civil and defense are the two key end-uses in the market. The civil end-use is further segmented into law enforcement, self-defense, and sports & hunting.

Advancements in Russian and U.S. regional markets coupled with increasing participation in shooting, hunting and sports across the world is influencing the growth of the global ammunition market. The countries such as China, South Korea, India, France, Saudi Arabia, Germany, Turkey, Israel and South Africa are expected to boost the demand further in the ammunition industry. However, high costs in research & development and international regulations are expected to hinder the market growth over the forecast period.

Additionally, the demilitarization initiatives adopted across Europe and North America are expected to reduce the demand for ammunition form the military and law enforcement sectors. However, the impacts of these factors are expected to reduce over the period of forecast.

View summary of this report @ http://www.grandviewresearch.com/industry-analysis/ammunition-market

Further key findings from the report suggest:

  • The global ammunition market size was estimated at USD 11.74 billion in 2015 and is expected to grow significantly by 2024 in light of technological advancements and development for the smart weapons to maintain law and order in developed economies.
  • Bullet segment is expected to witness considerable gains at a CAGR of 3.8% from 2016 to 2024. This growth is attributed to the measures taken by different governments to introduce latest technologies for the overall advancement of the industry.
  • AAI Corporation has developed an advanced light machine gun which uses 5.56mm ammo. This is also referred as telescoped ammunition and does not contain conventional brass cartridge, which reduces the weight approximately by 40% as compared to the traditional ammunition.
  • Asia Pacific accounted for 32.9% of the overall revenue share in 2015 and is projected to witness high growth. Recent increase in terrorist activities along with the need to maintain internal peace and order, counties such as India, China and Pakistan are continuously enhancing their defense mechanism, which in turn is boosting the market.
  • Ammunition industry is dominated by key participants including include General Dynamics Corporation, BAE Systems, Remington Arms Company, Inc., Ruag Ammotec, Poongsan Corporation, Federal Premium Ammunition and Maxam. Companies are collaborating in order to remain profitable and retain their position in the global market.

Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/automotive-and-aerospace-interior-materials

Grand View Research has segmented the global ammunition market on the basis of product, end-use and region:

Product Outlook (Revenue, USD Million, 2013 – 2024)

  • Bullet
  • Rocket
  • Mortar
  • Others

End-Use Outlook (Revenue, USD Million, 2013 – 2024)

  • Civil
    • Law Enforcement
    • Sports and Hunting
    • Self-defense
  • Defense

Regional Outlook (Revenue, USD Million, 2013 – 2024)

  • North America
    • S.
  • Europe
    • Russia
    • UK
    • France
  • Asia Pacific
    • China
    • India
  • Latin America
    • Brazil
    • Cuba
  • MEA
    • Saudi Arabia
    • Israel

Access press release of this report – http://www.grandviewresearch.com/press-release/global-ammunition-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

 

Contact:

Sherry James

Corporate Sales Specialist, U.S.A.

Grand View Research, Inc.

United States

Phone:  1-415-349-0058

Toll Free:  1-888-202-9519

Email:  sales@grandviewresearch.com

For more information visit – http://www.grandviewresearch.com/

Erythropoietin Drugs Market To Witness Growth Based On Increasing Incidence Of Chronic Diseases Such As End-Stage Renal Diseases And Cancer Till 2025

The global erythropoietin (EPO) drugs market is expected to reach USD 17.4 billion by 2025, according to a new report by Grand View Research, Inc. Rising incidence of chronic diseases such as CKD and cancer resulting in anemia is a major growth driver of this market.

According to the statistics published by the National Heart, Lung, and Blood Institute of the U.S. Department of Health & Human Services, over 3 million people are affected by anemia every year and this number is expected to increase over the forecast period. This showcases the need for erythropoietin-stimulating agents in the coming years.

Introduction of novel drugs and their cheaper biosimilar formulations with enhanced efficacy and cost-effectiveness is also expected to serve this industry with lucrative opportunities. For instance, development of numerous biosimilars in the European market is expected to gain traction and increase their usage rates, owing to associated benefits such as less time required for approval, cost-efficiency, and enhanced therapeutic effect.

Companies are involved in extensive R&D initiatives for development of innovative molecules and discovering new therapeutic areas for existing drugs. For instance, in April 2016, Sandoz received approval from the European Commission for use of its biosimilar Binocrit in nephrology indications, thereby extending the therapeutic area of its product portfolio.

Moreover, many of the industry players in the U.S., Europe, and Asia Pacific are involved in the development of new biosimilars. For example, Biocon’s subsidiary Syngene International entered into an agreement with Bristol-Myers Squibb to extend their drug discovery and development program in India. This enables Biocon to enhance its erythropoietin drugs portfolio. Expected product approvals in the coming years are anticipated to fuel market growth.

View summary of this report @ http://www.grandviewresearch.com/industry-analysis/erythropoietin-epo-drugs-market

Further key findings from the study suggest:

  • The biologics segment is declining over the forecast period owing to patent expiration of branded biologics and introduction of biosimilars in the market
  • The patent for Aranesp (darbepoetin-alfa) will expire in 2024 in the U.S. and is expected to provide numerous future growth opportunities for new market entrants
  • Epoetin-alfa held the largest share of product segment owing to its early introduction in the U.S. market and patent protection
  • Epoetin-omega and epoetin-zeta are anticipated to exhibit lucrative growth over the forecast period owing to associated benefits such as longer half-life and enhanced therapeutic effects
  • Use of erythropoietin drugs for treatment of renal diseases held a dominant share as of 2016 owing to the increasing incidence of chronic kidney diseases
  • The Asia Pacific regional industry for erythropoietin-stimulating agents is expected to witness lucrative CAGR during the forecast period
  • Industry participants are focusing on the discovery of new therapeutic areas for existing drugs and development of cost-effective biosimilars, thereby increasing R&D activities for the development of erythropoietin drugs.

Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/pharmaceuticals

Grand View Research has segmented the erythropoietin (EPO) drugs market on the basis of the drug class, product, application, and region:

Erythropoietin Drugs Drug class Outlook (Revenue, USD Million, 2014 – 2025)

  • Biologics
  • Biosimilar

Erythropoietin Drugs Product Outlook (Revenue, USD Million, 2014 – 2025)

  • Epoetin-alfa
  • Epoetin-beta
  • Darbepoetin-alfa
  • Others

Erythropoietin Drugs Application Outlook (Revenue, USD Million, 2014 – 2025)

  • Cancer
  • Hematology
  • Renal Diseases
  • Neurology

Erythropoietin Drugs Regional Outlook (Revenue, USD Million, 2014 – 2025)

  • North America
    • S.
    • Canada
  • Europe
    • Germany
    • UK
  • Asia Pacific
    • Japan
    • China
    • India
  • Latin America
    • Brazil
    • Mexico
  • MEA
    • South Africa

Access press release of this report – http://www.grandviewresearch.com/press-release/global-erythropoietin-epo-drugs-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

For more information visit – http://www.grandviewresearch.com/

Antiviral Drugs Market To Gain From Increased Sensitivity And Lower Adverse Effects Till 2025: Grand View Research, Inc.

The global antiviral drugs market is expected to reach a value of USD 69.2 billion by 2025, based on a new report by Grand View Research, Inc. According to the WHO, cases of viral infections increase by more than 1 million each year with around 357 million patients already suffering from one of the four Sexually Transmitted Infections (STIs), such as Acquired Immunodeficiency Syndrome (AIDS).

Introduction of efficient antiviral drugs with benefits such as rapid action, increased sensitivity, and lower adverse effects is expected to serve this market as a high-impact rendering driver over the forecast period. For instance, Gilead Sciences introduced an FDA-approved drug-Genvoya-in 2016 for treatment of AIDS patients who have previously faced adverse effects, such as bone loss and kidney dysfunction.

Low levels of hygiene, growing geriatric population, and increasing awareness through government campaigns are other drivers resulting in high acceptance of antiviral drugs in developing countries.

View summary of this report @ http://www.grandviewresearch.com/industry-analysis/antiviral-drugs-market

Further Key Findings From the Study Suggest:

  • Reverse transcriptase inhibitors held the largest share by mechanism of action owing to availability of wide range of product portfolio and presence of new molecules in clinical trials
  • Nucleotide inhibitors are estimated to grow at lucrative rate due to introduction of blockbuster molecules for treatment of Hepatitis C Virus (HCV) infections
  • Generic drugs are anticipated to witness significant CAGR of over 7.0% over the forecast period as result of patent expiry of blockbuster drugs used for treatment of HIV and HCV
  • Branded drugs will hold dominant position in 2025 by drug type due to brand loyalty of healthcare professions despite patent expiration and high price associated with these molecules
  • HIV/AIDS held the dominant share in 2015. High prevalence of HIV infections and presence of favorable government initiatives for curbing them are key factors for high revenue of this segment
  • Hepatitis on the other hand is anticipated to witness flourishing growth over the forecast period owing to introduction of new molecules and approval of novel combination treatments
  • North America was the dominant regional market in 2015. High market share is associated with established R&D infrastructure and growing drug development initiatives
  • Asia Pacific region is anticipated to exhibit fastest regional growth. Local presence of key generic players and growing healthcare infrastructure in this region are key factors for growth
  • Some of the key players of this market include Gilead Sciences; F. Hoffmann-La Roche AG; GlaxoSmithKline; Bristol-Myers-Squibb; AbbVie; Johnson & Johnson; and Merck & Co. Other generic players in this market are Aurobindo Pharma, Cipla, and Dr Reddy’s

Read our blog – http://www.grandviewresearch.com/blog/antiviral-drugs-market-size-share

Grand View Research has segmented the antiviral drugs market based on mechanism of action, type, application, and region:

Antiviral Drugs Mechanism of Action Outlook (Revenue, USD Billion; 2014 – 2025)

  • Nucleotide Polymerase Inhibitors
  • Reverse Transcriptase Inhibitors
  • Protease Inhibitors
  • Others

Antiviral Drugs Type Outlook (Revenue, USD Billion; 2014 – 2025)

  • Generic
  • Branded

Antiviral Drugs Application Outlook (Revenue, USD Billion; 2014 – 2025)

  • HIV
  • Hepatitis
  • Herpes Simplex Virus
  • Influenza
  • Others

Antiviral Drugs Regional Outlook (Revenue, USD Million, 2014 – 2025)

  • North America
    • S.
    • Canada
  • Europe
    • Germany
    • UK
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Mexico
    • Brazil
  • MEA
    • South Africa

Access press release of this report – http://www.grandviewresearch.com/press-release/global-antiviral-drugs-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

For more information visit – http://www.grandviewresearch.com/

Antimicrobial Packaging Market Is Expected To Reach USD 11.92 Billion By 2024: Grand View Research, Inc.

The global antimicrobial packaging market is expected to reach USD 11.92 billion by 2024, according to a new report by Grand View Research, Inc. Growing demand for confectionery & bakery products is expected to drive the global antimicrobial packaging market. Apart from bakery products, these agents are widely used in meat, poultry, seafood grain seeds, fruits, and vegetables.

Antimicrobial packaging releases active agents into food products which help to inhibit the growth of microorganisms and increase the shelf life. These releasing compounds maintain the food quality and reduce the need for preservatives and additives.

Antimicrobial active packaging is widely used in healthcare applications. These elements are specifically used to protect the plastic products, tablets and medical equipment against bacteria & fungal growth. Antimicrobial preservatives such as ethanol, phenol, cresol, parabens and bronopol can be added to pharmaceutical products to protect against microbial contamination.

However, antimicrobial agents derived from synthetic pathogenic sources are not found to satisfy consumers as they demand products extracted from natural sources. Such a factor is expected to hinder the overall market growth over the next eight years.

View summary of this report @ http://www.grandviewresearch.com/industry-analysis/antimicrobial-packaging-market

Further key findings from the report suggest:

  • The global antimicrobial packaging market demand was 6.51 million tons in 2015 and is expected to reach 10.09 million tons by 2024, growing at a CAGR of 5.0% from 2016 to 2024
  • Plastics were the leading base material used for antimicrobial packaging and accounted for 64.8% of total volume in 2015. Biopolymers are expected to witness the highest growth of 6.3% over the forecast period owing to its good physical, mechanical and chemical properties. In addition, they are recognized as an asset to waste processing.
  • Organic acid were the leading antimicrobial agents consumed and accounted for 37.3% of total market volume in 2015. Bacteriocins are expected to witness the highest growth of 5.4% over the forecast period.
  • Pouches emerged as the most dominant pack product and accounted for 39.2% of global volume in 2015. The segment is expected to witness similar trend in the near future due to its usage across different industries. Pouches are also expected to witness the highest growth of 5.5% over the forecast period.
  • Food & beverages were the most dominant application segment and accounted for 44.5% of total market volume in 2015. Stringent regulations regarding food safety across various regional markets have led to the increased penetration in the industry. The segment is also expected to witness the highest growth of 5.3% from 2016 to 2024. Moreover, controlled release packaging technology has been gaining wide importance for food packaging applications due to its impeccable response with respect to time.
  • Asia Pacific was the leading regional market and accounted for 33.3% of global demand in 2015. Busy lifestyle coupled with shifting preferences to consume ready to eat meals particularly in countries such as Japan, India and China has led to growth in the regional market. The region is also expected to witness the highest growth of 6.1% over the forecast period.
  • Key companies operating in the global market include Mondi Plc, BASF SE, Dow Chemicals, Dunmore Corporation, PolyOne Corporation, Linpac Senior Holdings, Bicote Corporation and Microban International. Agion Colorcon, a pharmaceutical company, is using a new antimicrobial product Agion Technologies, in their product line named No-Tox AM.

Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/food-safety-and-processing

Grand View Research has segmented the global antimicrobial packaging market on the basis of base material, antimicrobial agents, technology, pack type, application and region:

Antimicrobial Packaging Base Material Outlook (Volume, Kilo Tons; Revenue, USD Million, 2014 – 2024)

  • Plastics
  • Biopolymers
  • Paperboard
  • Others

Antimicrobial Packaging Antimicrobial Agents Outlook (Volume, Kilo Tons; Revenue, USD Million, 2014 – 2024)

  • Organic Acid
  • Bacteriocins
  • Others

Antimicrobial Packaging Technology Outlook (Volume, Kilo Tons; Revenue, USD Million, 2014 – 2024)

  • Active
  • Controlled release

Antimicrobial Packaging Pack Type Outlook (Volume, Kilo Tons; Revenue, USD Million, 2014 – 2024

  • Carton Packages
  • Pouches
  • Others

Antimicrobial Packaging Application Outlook (Volume, Kilo Tons; Revenue, USD Million, 2014 – 2024)

  • Food & Beverage
  • Healthcare
  • Personal Care
  • Others

Antimicrobial Packaging Regional Outlook (Volume, Kilo Tons; Revenue, USD Million, 2014 – 2024)

  • North America
    • S.
  • Europe
    • Germany
    • UK
    • Spain
  • Asia Pacific
    • China
    • India
  • Central & South America
    • Brazil
  • Middle East & Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

For More Information Visit – http://www.grandviewresearch.com/

 

 

Antimicrobial Additives Market To Reach USD 15.34 Billion By 2025: Grand View Research, Inc.

The global antimicrobial additives market size is expected to reach USD 15.34 billion by 2025, according to a new report by Grand View Research, Inc. The growing demand for healthcare products such as medical devices and disposables in emerging economies including India and China will fuel growth over the forecast period. Furthermore, increasing awareness among consumers regarding hospital acquired infections (HAIs) is expected to propel the demand for products with antimicrobial properties further.

The usage of antimicrobial additives in the packaging industry will witness considerable revenue growth at a CAGR of 7.1% from 2016 to 2025. These additives are added to the plastic products to prevent spoilage of food, beverages, and medicines due to microbial contamination. Moreover, the rising number of fast food chains and restaurants are anticipated to drive the demand for packaging thereby increasing product demand. In addition, the increasing usage of these additives in the paper for packing medicines and food will create immense growth opportunities over the forecast period.

View summary of this report @ http://www.grandviewresearch.com/industry-analysis/antimicrobial-additives-market

Further key findings from the report suggest:

  • The global antimicrobial additives market demand was 57.4 kilo tons in 2015 and is projected to grow significantly on account of swift healthcare expansion in emerging countries such as China, India, Brazil, Mexico, Singapore, Saudi Arabia, and Thailand
  • Europe accounted for 22.5% of the global volume share in 2015 and is anticipated to witness growth in light of rising consumer demand for antimicrobial packaging, healthcare, food & beverage and paints & coatings products over the upcoming years
  • Inorganic antimicrobial additives are expected to witness significant volume growth at a CAGR of 8.3% from 2016 to 2025 on account of increasing usage of silver ion. Excellent antimicrobial properties along with low toxicity of silver will spur market demand in the future.
  • The industry is dominated by key participants including AkzoNobel N.V., BASF SE, Dow Chemical Company, BioCote Limited, Sanitized AG, SteriTouch Limited, Life Material Technologies Limited, Nanobiomatters Industries S.L., Momentive Performance Material Inc., Clariant, Microban International, A. Schulman, Inc., Milliken Chemical, RTP Company, and Plastics Color Corporation
  • Companies are focusing on extensive research to develop innovative products and technologies. For instance, in October 2016, Sanitized AG introduced Sanitized PL 14-32, a highly effective product for long-lasting antimicrobial protection for flexible polymer applications.

Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/plastics-polymers-and-resins

Grand View Research has segmented the global antimicrobial additives market on the basis of type, application, end-use and region:

Type Outlook (Volume, Tons; Revenue, USD Million, 2014 – 2025)

  • Organic
  • Inorganic

Application Outlook (Volume, Tons; Revenue, USD Million, 2014 – 2025)

  • Plastics
  • Paints & coatings
  • Pulp & paper
  • Others

End-Use Outlook (Volume, Tons; Revenue, USD Million, 2014 – 2025)

  • Healthcare
  • Packaging
  • Food & beverages
  • Construction
  • Automotive
  • Others

Regional Outlook (Volume, Tons; Revenue, USD Million, 2014 – 2025)

  • North America
    • S.
  • Europe
    • Germany
    • UK
  • Asia Pacific
    • China
    • India
  • Latin America
    • Brazil
  • MEA

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

For More Information Visit – http://www.grandviewresearch.com/

 

Antibody Production Market To Gain From Increasing Demand For Therapeutic Antibodies Including Monoclonal And Polyclonal Antibodies Till 2025

The global antibody production market is expected to reach a value of USD 22.6 billion by 2025, according to a new report by Grand View Research, Inc. Increasing demand for therapeutic antibodies including monoclonal and polyclonal antibodies is a major factor that drives growth of the market during forecast period. Antibodies are the dominant biopharmaceuticals that specifically target the abnormal cells. Thus, many pharmaceuticals and biotechnology companies have begun to focus on the development of advanced antibodies for the treatment of chronic diseases such as cancer, rheumatic heart disease, and arthritis.

Patent expiry of several blockbuster monoclonal antibodies in the near future, is another major factor supporting the growth of the antibody production market. Several antibodies such as Avastin, Herceptin, and Mabthera are going to lose their patents in a few years. For instance, the patent of Herceptin (trastuzumab) expired in Europe in July 2014 and will expire in the U.S. in June 2019. Many companies such as Amgen Inc., Synthon, Biocon, and Pfizer Inc. are developing biosimilar for trastuzumab, which is expected to propel the demand for antibody production products.

View summary of this report @ http://www.grandviewresearch.com/industry-analysis/antibody-production-market

Further key findings from the study suggest:

  • Downstream processing was the largest revenue-grossing segment of the antibody production market in 2016. It is also expected to exhibit the highest CAGR during the forecast period, owing to large application of chromatography devices and resins in downstream processing
  • The monoclonal antibody segment was leading in 2016, due to its higher demand in treatment of chronic diseases including cancer, blood disorders, and growth hormone deficiency
  • The pharmaceutical and biotechnology companies segment dominated the overall market in terms of revenue in 2016, owing to the large production of therapeutic antibodies and high investment in R&D by companies for drug development
  • North America was the largest revenue-generating region of the market in the year 2016. This region is expected to maintain its position during the forecast period because of the presence of several leading biopharmaceuticals and biotechnology companies in this region
  • Asia Pacific region is projected to be the fastest-growing segment over the study period, due to rapidly booming biotechnology industry and comparatively less stringent regulations for biologics development in APAC region
  • Some of the key players include GE Healthcare; Thermo Fisher Scientific, Inc.; Sartorius AG; Merck KGaA; Pall Corp.; Eppendorf AG; Cellab GmbH; INTEGRA Biosciences AG; and FiberCell Systems Inc.

Read our blog – http://www.grandviewresearch.com/blog/antibody-production-market-size-share

Grand View Research has segmented the antibody production market on the basis of type, process, end-use, and region:

Antibody Production Type Outlook (Revenue, USD Million; 2014 – 2025)

  • Polyclonal antibody
  • Monoclonal antibody
    • Murine
    • Chimeric
    • Humanized

Antibody Production Process Outlook (Revenue, USD Million; 2014 – 2025)

  • Upstream processing
    • Bioreactors
      • Largescale bioreactors
      • Single-use bioreactors
    • Consumables
      • Media
      • Buffers and reagents
    • Downstream processing
      • Chromatography systems
      • Chromatography resins
    • Filtration
      • Filtration systems
      • Filtration consumables and accessories

Antibody Production End-Use Outlook (Revenue, USD Million; 2014 – 2025)

  • Pharmaceutical and biotechnology companies
  • Research laboratories
  • Others

Antibody Production Regional Outlook (Revenue, USD Million; 2014 – 2025)

  • North America
    • S.
    • Canada
  • Europe
    • Germany
    • UK
  • Asia Pacific
    • Japan
    • China
    • India
  • Latin America
    • Brazil
    • Mexico
  • MEA
    • South Africa

Access press release of this report – http://www.grandviewresearch.com/press-release/global-antibody-production-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

For more information visit – http://www.grandviewresearch.com/